Published in
BMJ Publishing Group, Journal for ImmunoTherapy of Cancer, 1(6), 2018
DOI: 10.1186/s40425-018-0436-5
Links
Tools
STAT3 antisense oligonucleotide AZD9150 in a subset of patients with heavily pretreated lymphoma: results of a phase 1b trial
Journal article published in 2018 by
Matthew J. Reilley,
Patricia McCoon,
Carl Cook,
Paul Lyne,
Razelle Kurzrock,
Youngsoo Kim,
Richard Woessner,
Anas Younes,
John Nemunaitis,
Nathan Fowler,
Michael Curran 
,
Qinying Liu,
Tianyuan Zhou,
Joanna Schmidt,
Minji Jo
and other authors.
,
Qinying Liu,
Tianyuan Zhou,
Joanna Schmidt,
Minji Jo
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Data provided by 